Business Context and Reporting Period
Company: Gartner Group, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: June 30, 1999 (Third Quarter of Fiscal Year 1999)
Business Overview: Gartner provides advisory, measurement, consulting, and conference services to the information technology industry. The company operates on a contract renewal model with significant seasonality, typically seeing peak contract value growth in the fourth quarter.
Key Financial Metrics
| Metric | Q3 1999 (3 Months) | Q3 1998 (3 Months) | YTD 1999 (9 Months) | YTD 1998 (9 Months) |
|---|---|---|---|---|
| Total Revenues | $185.7 million | $161.0 million | $547.4 million | $473.2 million |
| Operating Income | $38.1 million | $35.5 million | $123.5 million | $107.7 million |
| Net Income | $26.4 million | $23.0 million | $85.3 million | $68.7 million |
| Diluted EPS | $0.25 | $0.22 | $0.80 | $0.65 |
| Operating Margin | 20.6% | 22.1% | 22.6% | 22.8% |
| Cash from Operations (YTD) | $69.1 million (vs. $62.3 million YTD 1998) | |||
| Cash & Equivalents (End of Period) | $211.2 million | |||
| Total Debt | None reported on balance sheet as of June 30, 1999 |
Material Changes vs. Prior Period
- Revenue Growth: Total revenues increased 15% in Q3 and 16% YTD compared to the prior year. Excluding the sold GartnerLearning business, ongoing revenue grew 19%.
- Segment Performance: Advisory and measurement revenues grew 10% in Q3. "Other" revenues (consulting and conferences) surged 50% in Q3, driven by geographic expansion and acquisitions.
- Contract Value: Increased 14% to $608.4 million, indicating strong client retention and new business volume.
- Nonrecurring Charges: The company recorded $1.5 million in nonrecurring charges in Q3 and $5.9 million YTD, primarily related to legal/advisory fees for recapitalization and severance from reorganization.
- Tax Benefit: A one-time income tax benefit of $2.5 million was recorded in Q2 due to the settlement of federal income tax examinations.
Guidance, Outlook, and Risks
Management Commentary and Subsequent Events
- Recapitalization: Following shareholder approval in July 1999, the company split its stock into Class A and Class B. Class B shares were spun off to IMS Health stockholders.
- Dividend: A special nonrecurring cash dividend of $1.1945 per share (approx. $125 million total) was paid on July 22, 1999, funded by existing cash.
- Share Repurchase: The company initiated a Dutch Auction tender offer to repurchase approximately 15% of outstanding shares (up to 15.7 million shares) at prices between $21.00 and $24.00. An additional 5 million shares are planned for open market purchase over two years.
- Debt Financing: To fund the repurchase, the company entered a $500 million credit facility ($350 million term loan, $150 million revolver) with Chase Manhattan Bank.
- Acquisition: Acquired The Warner Group for $18.0 million in cash in July 1999.
Risks and Contingencies
- Indemnification Liability: The company agreed to indemnify IMS Health for potential taxes arising from the spin-off, with potential liabilities estimated at $300 million or more.
- Year 2000 Issues: Identified Y2K costs were $4.1 million YTD. The company faces uncertainty regarding client spending shifts toward Y2K remediation.
- Competition and Talent: Intense competition for qualified IT analysts and personnel retention risks following the recapitalization.
- Seasonality: Operating margins are typically lower in Q3 and Q4 compared to Q1 and Q2 due to spending patterns and conference timing.
Investor Verification Checklist
- Debt Covenants: Verify compliance with the new $500 million credit facility covenants given the recent recapitalization and dividend payout.
- Repurchase Execution: Monitor the final price and volume of the Dutch Auction tender offer and subsequent open market purchases.
- Indemnification Exposure: Assess the probability and potential impact of the $300 million+ tax indemnification obligation to IMS Health.
- Y2000 Impact: Confirm if client demand for advisory services is shifting due to Y2000 remediation budget allocations.
- Contract Renewals: Validate the 85% client renewal rate and its correlation to future revenue stability.